Net specialty spend reached $1,251 PMPY in 2025, driven primarily by rising utilization and member penetration, rather than ...

A randomized, open-label comparison in 31 children (mostly cerebral palsy) evaluated VR plus nitrous oxide versus standard distraction approaches during botulinum toxin injections. Pain scores ...

Retinal anti-VEGF regimens requiring frequent monitoring generate indirect patient costs that often outweigh direct expenses ...

Management tools are intensifying across markets, including more prior authorization, step therapy, formulary exclusions, and biosimilar preferencing, with spillover from Part D into commercial ...

Require each hospital and care provider to post a single commercial (private insurance) price for each care location, expressed as a simple multiple of the price Medicare pays.

For individuals living with chronic conditions, stable housing enables consistent care. Conversely, housing instability can disrupt care continuity, increase financial strain, and contribute to ...

Edward Machtinger, M.D., of UCSF says most mental illness and substance use trace back to trauma, and clinics that ignore this can retraumatize patients.

CMS will terminate the Part D premium stabilization subsidies for standalone PDPs in 2027, citing mature sponsor pricing under IRA benefit redesign and a return to “traditional market conditions.” ...

Simtriyo’s mechanism combines norepinephrine/dopamine augmentation with serotonin modulation, expanding beyond traditional stimulant and selective nonstimulant approaches for heterogeneous ADHD ...

Medicare Advantage plans will see a 5.06% payment increase in 2026, offering stability but favoring larger managed care organizations. Concerns persist over MA's higher cost to the federal government, ...

AVAC Executive Director Mitchell Warren says HIV prevention science has never been stronger, even as funding cuts have left program infrastructure badly weakened. HIV prevention science has never been ...